期刊文献+

CRISPR/Cas9高通量筛选技术与肿瘤治疗 被引量:6

Application of CRISPR/Cas9 High-throughput Screening Technology for Identifying New Target in Tumor Therapy
下载PDF
导出
摘要 成簇规律间隔短回文重复(CRISPR),是细菌或古菌在与噬菌体长期生存进化获得的一种免疫系统。根据Cas蛋白(CRISPR-associated protein)的不同,CRISPR系统可分为3种。其中Ⅱ型CRISPR/Cas9已被改造成为一种有效的基因编辑工具,并运用于多种物种基因的改造。作为1种基因编辑的手段,CRISPR/Cas9技术通过诱导DNA双链断裂损伤,进一步干扰基因的表达。与传统的基因编辑技术相比,CRISPR/Cas9技术显示出效率高、成本低和易操作等特点。与此同时,二代测序技术的发展促进全基因组的解析。CRISPR技术结合高通量二代测序手段的使用,在肿瘤的治疗领域中已发挥出了独特的优势。本文就近年来CRISPR/Cas9高通量筛选技术的发展,及其在肿瘤治疗过程中的应用进行综述。 Clustered regularly interspaced short palindromic repeats( CRISPR) is an acquired immunity system during the defensive processes of bacteria or archaea against bacteriophage. Basing on the difference about Cas proteins( CRISPR-associated protein),CRISPR system could be divided into three different types. Type Ⅱ CRISPR system-CRISPR/Cas9 has been modified to disturb gene function in various species. As a new gene editing tool,CRISPR/Cas9 technique could be employed to interrupt the expression of gene via triggering DNA double strand break( DSB). Compared with traditional gene modifying technologies,for example,RNA interference( RNAi),TALEN( transcription activator-like effector nucleases),and ZFN( zinc finger nuclease),CIRSPR/Cas9 system is possessed of some advantages such as high-efficiency,low-cost,and easy-operation. Additionally,rapid development of next-generation sequencing( NGS) technology accelerates whole genome analysis. Therefore,CRISPR system combined with high-throughput NGS technology has displayed a unique advantage in tumor therapy. Hitherto there are three kinds of high-throughput tools based on CRISPR techniques,including CRISPR,CRISPR activation( CRISPRa),and CRISPR interference( CRISPRi). Here,we briefly summarized these three high-throughput screen strategies and discussed the related applications during different processes of cancer.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2016年第2期133-139,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金(No.31329003 No.81402331)资助~~
关键词 成簇规律间隔短回文重复 高通量筛选 肿瘤 靶点 clustered regularly interspaced short palindromic repeat(CRISPR) high-throughput screen tumor target
  • 相关文献

参考文献43

  • 1Schramek D, Sendoel A, Segal J P, et al. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas [J]. Science, 2014, 343(6168): 309-313.
  • 2Sroczynska P, Cruickshank V A, Bukowski J P, et al. shRNA screening identifies JMJD1C as being required for leukemia maintenance [ J]. Blood, 2014, 123(12) : 1870-1882.
  • 3Kranz D, Boutros M. A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis [ J]. EMBO J, 2014, 33(3) : 181-197.
  • 4Oosterkamp H M, Hijmans E M, Brummelkamp T R, et al. USP9X downregulation renders breast cancer ceils resistant to tamoxifen [ J]. Cancer Res, 2014, 74 (14) : 3810-3820.
  • 5Mohr S E, Smith J A, Shamu C E, et al. RNAi screening comes of age: improved techniques and complementary approaches [ J]. Nat Rev Mol Cell Biol, 2014, 15(9) : 591-600.
  • 6Buehler E, Khan A A, Marine S, et al. siRNA off-target effects in genome-wide screens identify signaling pathway members [ J]. Sci Rep, 2012, 2:428-433.
  • 7Sigoillot F D, Lyman S, Huckins J F, et al. A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens [J]. Nat Methods, 2012, 9(4) : 363-366.
  • 8Jansen R, Embden J D, Gaastra W, et al. Identification of genes that are associated with DNA repeats in prokaryotes [ J ]. Mol Microbiol, 2002, 43(6): 1565-1575.
  • 9Andersson A F, Banfield J F. Virus population dynamics andacquired virus resistance in natural microbial communities [ J ]. Science, 2008, 320 (5879) : 1047-1050.
  • 10Bhaya D, Davison M, Barrangou R. CRISPR-Cas systems in bacteria and arehaea: versatile small RNAs for adaptive defense and regulation [J]. Annu Rev Genet, 2011, 45:273-297.

二级参考文献5

共引文献12

同被引文献31

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部